Literature DB >> 22508811

Elusive goal of targeting tumor hypoxia for therapeutic gain.

Lester Peters, Danny Rischin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22508811     DOI： 10.1200/JCO.2011.40.8294

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

2.  Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.

Authors:  Aron Popovtzer; Daniel Normolle; Francis P Worden; Mark E Prince; Douglas B Chepeha; Gregory T Wolf; Carol R Bradford; Theodore S Lawrence; Avraham Eisbruch
Journal:  Transl Oncol       Date:  2014-08       Impact factor: 4.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.